Depression Among Medical Students at Sohag University

February 16, 2026 updated by: Basant Hemaid Mustafa, Sohag University

Introduction Depression is one of the most prevalent mental health disorders globally, significantly impacting individuals' quality of life, academic performance, and overall functioning. According to the World Health Organization (WHO), depression affects more than 264 million people worldwide, and it is considered a leading cause of disability. Among young adults, particularly students, the condition is increasingly common and often underdiagnosed and undertreated (1).

Medical students are at a disproportionately higher risk of depression compared to the general population due to the intense academic workload, pressure to perform, competitive environment, and exposure to human suffering during clinical training (2). A meta-analysis found that approximatel…

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: areeg abbas yossef, doctor
  • Phone Number: 01050134174 +201000715833

Study Locations

    • Sohag Governorate
      • Sohag, Sohag Governorate, Egypt, 82511
        • Sohag faculty of medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

medical students at sohag university

Description

Inclusion Criteria:

  • from 18 to 25 yrs medical student

Exclusion Criteria:

  • less than 18 yrs

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
medical student
no intervention
The questionnaire was constructed to comprehensively assess depression symptoms alongside relevant socio-demographic and lifestyle factors that may be associated with mental health outcomes among medical students.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
prevalence of depression
Time Frame: 6 months
depression is common among medical student
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Taher Abd - Elraheem, Professor, Sohag University
  • Study Director: Osama abdelrahem Mahmoud, Lecturer, Sohag University
  • Study Director: Osama Eltaher, Lecturer, Sohag University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

March 1, 2026

Primary Completion (Estimated)

September 28, 2026

Study Completion (Estimated)

September 28, 2026

Study Registration Dates

First Submitted

February 16, 2026

First Submitted That Met QC Criteria

February 16, 2026

First Posted (Actual)

February 23, 2026

Study Record Updates

Last Update Posted (Actual)

February 23, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

the aim of work and the result

IPD Sharing Time Frame

6 months

IPD Sharing Access Criteria

any researcher interested

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression - Major Depressive Disorder

Clinical Trials on Questionnaire

Subscribe